A standardized definition of ischemic cardiomyopathy for use in clinical research

Journal of the American College of Cardiology

Volumn 39, Issue 2, 2002, Pages 210-218

  Felker, G Michael ^a,b   Shaw, Linda K ^a   O'Connor, Christopher M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL RESEARCH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; SURVIVAL;

AGED; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 0037116527     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01738-7     Document Type: Article

References (17)

1. Chronic heart failure in the United States: A manifestation of coronary artery disease
2. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy
3. Relation between gender, etiology and survival in patients with symptomatic heart failure
4. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
5. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
6. Etiology and response to drug treatment in heart failure
7. Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the Assessment of Treatment with Lisinopril And Survival (ATLAS) trial
8. Segmental wall motion abnormalities in dilated cardiomyopathy: A common finding and good prognostic sign
9. Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
10. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
11. Outcome in medically treated coronary artery disease: Nonfatal infarction and death
12. National sources of vital status information: Extent of coverage and possible selectivity in reporting
13. Ischemic cardiomyopathy: Endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy, and coronary artery disease
14. Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: Comparison of idiopathic dilated cardiomyopathy and coronary artery disease
15. Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure
16. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography
17. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy